Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies
Authors:
- Pd KottaridisPKPd Kottaridis
- HH McGarrigleHMHH McGarrigle
- Dc LinchDLDc Linch
- 1 April 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (7) , 607-610
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 16 references indexed in Scilit:
- Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunctionClinical Endocrinology, 2000
- Erectile DysfunctionNew England Journal of Medicine, 2000
- Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignanciesBone Marrow Transplantation, 2000
- Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myelomaThe Lancet, 2000
- Erectile Dysfunction in the Cancer PatientCancer Control, 2000
- Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunctionBritish Journal of Cancer, 2000
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceJAMA, 1993
- Principles of the new sex therapyAmerican Journal of Psychiatry, 1976
- Group treatment of premature ejaculationArchives of Sexual Behavior, 1974